BioPharm International September October 2026

Next-gen bioprocessing, cloud-driven AI, and personalized immunizations are accelerating global therapy delivery while reinforcing cleanroom and trial compliance.

Decentralized clinical trials can reduce patient burden and expand access, but they also introduce new challenges for clinical trial logistics, supply chain management, technology, data, and regulatory oversight.

Keith Knutson, PhD, of Mayo Clinic explains why vaccine manufacturing speed and cost will determine real-world scalability.

Structured fixed-bed bioreactors offer vaccine manufacturers a scalable, lower-cost alternative to roller bottles and microcarrier systems.

New data show risk-based and centralized monitoring shifts effort across roles, sites, and timelines, reshaping how sponsors plan CRA capacity needs.

As data volumes explode, clinical data harmonization, hybrid cloud, and AI are reshaping biopharma IT into the industry's core growth engine.

GMP cleanroom differential pressure control prevents FDA 483 citations and contamination failures through HVAC design and validation.